Adimab vs Antiverse
Adimab vs Antiverse, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adimab is on 53/100 and Antiverse on 52/100.
Where each one leads
Adimab
- headcount: 139 against 28
- funding raised: $105M against $15.7M
Antiverse
- agent readiness: 50/100 against 40/100
At a glance
| Measure | Adimab | Antiverse |
|---|---|---|
| What it is | Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform. | AI-powered antibody discovery platform. |
| Category | Biotech, Drug Discovery, Antibody Discovery, Therapeutic Antibodies | Biotechnology, Artificial Intelligence, Drug Discovery, Pharmaceuticals |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2007 | 2018 |
| Headquarters | Lebanon, United States | London, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | Adimab | Antiverse |
|---|---|---|
| Employees | 139 | 28 |
| Total funding | $105M | $15.7M |
| Latest round | Series B | Series A |
| LinkedIn followers | 8,423 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adimab | Antiverse |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 52/100 |
| Traction | 60/100 | 51/100 |
| Team | Not published | 70/100 |
| Search visibility | 20/100 | 8/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 39/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adimab | Antiverse |
|---|---|---|
| Hosting | AWS | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Bootstrap | Not detected |
| Analytics | Google Tag Manager, Linkedin Insight | Not detected |
| Support stack | HubSpot | Not detected |
Adimab vs Antiverse: common questions
Which is better, Adimab or Antiverse?
On our 0-100 score Adimab rates higher (53/100 against 52/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Adimab and Antiverse compare on the numbers?
Adimab leads on headcount (139 against 28), funding raised ($105M against $15.7M). Antiverse leads on agent readiness (50/100 against 40/100).
Read the full Adimab review and pricing or the Antiverse review and pricing. You can also browse other Adimab alternatives we track.